Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study-Reference-Cited by-同舟云学术

Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study

Published:2021-03 Issue: Volume:282 Page:1272-1277
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Ramsey Christine M.,Lynch Kevin G.,Thase Michael E.,Gelernter Joel,Kranzler Henry R.,Pyne Jeffrey M.,Shih Mei-Chiung,Stone Annjannette,Oslin David W.

Funder

U.S. Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference19 articles.

1. Clinical validity: combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes;Altar;Pharmacogenomics. J.,2015

2. GeneSight® psychotropic report details,2019

3. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study;Greden;J. Psychiatry Res.,2019

4. VA/DoD clinical practice guideline for the management of major depressive disorder,2016

5. Using a pharmacogenomic algorithm to guide the treatment of depression;Hall-Flavin;Transl. Psychiatry,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic Clinical Support Tools for the Treatment of Depression;American Journal of Psychiatry;2024-07-01

2. Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients;Molecular Psychiatry;2024-05-23

3. Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors;Journal of Affective Disorders;2023-04

4. Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway;Journal of Neuroinflammation;2022-05-24